Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile Jun 3, 2023 09:00AM
Cyteir Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights May 10, 2023 04:01PM
Cyteir Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 23, 2023 04:01PM
Cytec Industries (CYT) Promotes David Gaiero to Chief Financial Officer Feb 6, 2023 08:15AM
Cyteir Therapeutics Promotes David Gaiero to Chief Financial Officer Feb 6, 2023 08:15AM


Jan 19, 2023 04:30PM Cytec Industries (CYT) Prioritizes CYT-0851 Development and Extends Cash Runway
Jan 19, 2023 04:30PM Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway
Nov 7, 2022 04:01PM Cyteir Therapeutics Reports Third Quarter 2022 Financial Results and Operational Highlights
Oct 12, 2022 08:00AM Cyteir Therapeutics Presents Poster on the Identification of Mechanism of Action of CYT-0851 at the 34th Annual EORTC-NCI-AACR Symposium
Aug 31, 2022 07:30AM Cyteir Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Aug 8, 2022 04:01PM Cyteir Therapeutics Reports Second Quarter 2022 Financial Results and Operational Highlights
Aug 1, 2022 08:00AM Cyteir Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
Jun 6, 2022 05:50AM Cytec Industries (CYT) Reports Positive Phase 1 Dose Escalation Results of CYT-0851
Jun 5, 2022 08:30AM CYT-0851 Phase 1 Dose Escalation Results Show Early Clinical Activity and Generally Well Tolerated Safety Profile in Advanced Solid Tumors and Hematologic Malignancies
May 31, 2022 08:00AM Cyteir Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
May 5, 2022 04:30PM Cyteir Therapeutics Reports First Quarter 2022 Financial Results and Operational Highlights
May 4, 2022 08:00AM Cyteir Therapeutics to Participate in the 2022 Bank of America Healthcare Conference
May 3, 2022 09:00AM Cyteir Therapeutics Names Krisztina Nemenyi as Senior Vice President of Regulatory Affairs and Quality
Apr 25, 2022 09:00AM Cyteir Therapeutics Names Adam Veness General Counsel
Apr 18, 2022 07:30AM Cyteir Therapeutics to Host Virtual Research and Development (R&D) Day on April 26, 2022
Oct 20, 2015 06:49AM Fluor Awarded Cytec’s UK Adhesives Expansion Project
Jul 31, 2015 03:54PM Top 10 News for 7/27 - 7/31: Teva Makes it Official with Allergan; China Stock Slide Continues; Revised Q2 GDP Misses Mark
Jul 30, 2015 11:37AM Cytec Industries Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover
Jul 29, 2015 09:28AM Pre-Open Stock Movers 07/29: (CYT) (RUBI) (BWLD) Higher; (YELP) (DATA) (TWTR) Lower (more...)